Core Insights - LegalZoom.com has a competitive advantage due to its extensive service offerings and the ability to connect customers with automated tools and professional expertise [1] - The company operates in the specialty business services segment, focusing on simplifying complex legal processes for small businesses and consumers through a user-friendly digital platform [1] Financial Performance - LegalZoom generated $756 million in total sales for the full year of 2025, reflecting an 11% year-over-year growth [7] - Subscription sales reached $492.5 million, marking a 13% increase over 2024, which is significant as subscription income represents recurring revenue [8] Shareholder Activity - On February 26, 2026, Chief Legal Officer Nicole Miller sold 23,325 shares, reducing her direct holdings by 2.79% to 813,033 shares, approximately 0.46% of outstanding shares [3][4] - The sale was part of a Rule 10b5-1 trading plan adopted in November 2025, indicating it was a pre-planned transaction [5][6] Market Reaction - LegalZoom's stock price was around $6.63 per share at the time of the sale, with a one-year total return of -30.15%, indicating a decline in share price [2] - Concerns about artificial intelligence potentially replacing LegalZoom's services have affected stock performance, but the company is expected to maintain its relevance for critical legal needs [7] Investment Considerations - Despite the recent share price decline and market fears, LegalZoom's business is showing healthy growth, suggesting it may be a good opportunity for investors to buy rather than sell [8] - The Motley Fool Stock Advisor did not include LegalZoom in its list of the 10 best stocks for investors to buy now, which may influence investor sentiment [9]

Core Insights - LegalZoom.com, Inc. provides online legal solutions for small businesses and individuals, facing competition from peers like Xometry, Cyteir Therapeutics, CS Disco, LifeStance Health Group, and Clear Secure [1] Financial Performance - LegalZoom's Return on Invested Capital (ROIC) is 6.34%, while its Weighted Average Cost of Capital (WACC) is 9.32%, resulting in a ROIC to WACC ratio of 0.68, indicating insufficient returns above its cost of capital [2] - Xometry, Inc. has a negative ROIC of -7.94% against a WACC of 7.29%, leading to a ROIC to WACC ratio of -1.09, highlighting similar challenges in capital efficiency [3] - Cyteir Therapeutics, Inc. and CS Disco, Inc. exhibit even greater inefficiencies with ROICs of -32.37% and -46.98%, respectively, and WACC figures of 5.19% and 13.20%, resulting in ROIC to WACC ratios of -6.24 and -3.56 [4] - In contrast, Clear Secure, Inc. demonstrates strong performance with a ROIC of 33.80% and a WACC of 9.10%, yielding a ROIC to WACC ratio of 3.72, indicating effective capital utilization [5][6]